MDxHealth (MDXH) FCF Margin (2021 - 2026)

MDxHealth (MDXH) posted FCF Margin of 27.99% for Q1 2026, up 195.46% sequentially from 29.32% in Q3 2025, and up 4492.0% YoY from 0.61% in Q1 2025.

MDxHealth (MDXH) FCF Margin (2021 - 2026) Analysis & Trends

MDxHealth (MDXH) has 6 years of FCF Margin data on file, last reported at 27.99% in Q1 2026.

Quarterly FCF Margin rose 4492.0% year-over-year to 27.99% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (up 3958.0% YoY) and the FY2025 annual result came in at 3.11%, up 2566.0% from the prior year.
FCF Margin grew to 27.99% in Q1 2026 per MDXH's latest filing, from 29.32% in the prior quarter.
The five-year high for FCF Margin was 144.66% in Q2 2022, with the low at 119.29% in Q1 2022.
Average FCF Margin over 5 years is 17.58%, with a median of 26.34% recorded in 2024.
Year-over-year, FCF Margin sank 19090 bps in 2023 and jumped 9307 bps in 2025.
MDxHealth's FCF Margin stood at 144.66% in 2022, then plunged by 132 bps to 46.24% in 2023, then soared by 41 bps to 27.45% in 2024, then slipped by 7 bps to 29.32% in 2025, then soared by 195 bps to 27.99% in 2026.
Business Quant data shows MDXH's FCF Margin at 27.99% in Q1 2026, 29.32% in Q3 2025, and 0.01% in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn	-3.31%
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn	7.41%
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn	18.23%
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn	22.61%
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn	2.59%
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn	10.95%
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn	11.83%
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn	23.01%
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn	12.92%
10	MDxHealth	111.80 Mn	68.64 Mn	16.61 Mn	-25.35%

Download Data